Alzheimer's Disease: FDA greenlights first-of-its-kind blood test for Alzheimer's disease: How does it work?
The US Food and Drug Administration (FDA) has granted marketing clearance for a new blood test designed to assist in the diagnosis of Alzheimer's disease, marking it as the first test approved in the United States for the early detection of this condition.
Tired of too many ads? go ad free now
How does the blood test work?
Named the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, this test is intended for adults aged 55 and older who exhibit signs and symptoms of Alzheimer's. The FDA announced this development on a Friday, highlighting the significance of the test that analyzes two specific proteins in blood plasma: pTau217 and beta-amyloid 1-42. The ratio of these proteins is known to correlate with the presence or absence of amyloid plaques in the brain, which are characteristic markers of Alzheimer's disease, although the test does not directly measure amyloid levels.
Currently, there is no singular test for diagnosing Alzheimer's disease. Physicians typically utilize a comprehensive approach that includes an evaluation of medical history, neurological exams, cognitive and functional assessments, brain imaging, spinal fluid analysis, and, more recently, blood tests. The results from this newly approved blood test will need to be interpreted alongside other clinical information pertaining to the patient.
FDA Commissioner Dr. Martin Makary emphasized the profound impact of Alzheimer's disease on the population, noting that it affects more individuals than breast and prostate cancer combined. He pointed out that approximately 10% of people aged 65 and older are living with Alzheimer's, a figure expected to double by 2050. Dr. Makary expressed optimism that innovative medical products, like this blood test, will significantly benefit patients.
Tired of too many ads? go ad free now
A new hope:
Developed by Fujirebio Diagnostics Inc., a biotechnology company based in Pennsylvania, the new blood test aims to improve access to Alzheimer's detection and lessen the reliance on positron emission tomography (PET) scans. PET scans can reveal the presence of amyloid plaques in the brain, but they are often costly, sometimes amounting to thousands of dollars without insurance coverage.
The FDA assessed clinical trial data involving plasma samples from 499 cognitively impaired adults.
The study compared the blood test results with findings from PET scans or cerebrospinal fluid analysis, such as results from spinal taps. According to the FDA, the data demonstrated that 91.7% of the adults with positive blood test outcomes had confirmed amyloid plaques via their PET scans or cerebrospinal fluid tests, while 97.3% of those with negative blood test results also had negative outcomes in their PET scans or cerebrospinal fluid tests.
The agency cautioned that the main risks associated with this blood test involve the potential for false-positive or false-negative results.
The new era:
A "new era" in Alzheimer's research is emerging, highlighted by recent advancements in diagnostic methods. Dr. Richard Isaacson, a preventive neurologist and pioneer in Alzheimer's prevention, has been utilizing an FDA-cleared blood test in his research for several years.
This test helps determine whether individuals experiencing memory loss may be suffering from Alzheimer's disease. According to Isaacson, this blood test serves as a simpler and more cost-effective alternative to traditional diagnostic methods, such as PET scans or spinal taps.
While the FDA's approval represents significant progress, Isaacson cautions that further research is essential to clarify how the results of this blood test should be interpreted and applied in clinical settings.
He emphasizes the need for enhanced education surrounding the implications of the test results, noting that their meaning can vary based on individual risk factors and symptoms.
Fujirebio Diagnostics developed this blood test to facilitate early detection of Alzheimer's disease, which is crucial for timely intervention. Monte Wiltse, the company's president and CEO, stated that accurate, early diagnosis could drive the creation of new drug therapies, especially given the increasing prevalence of Alzheimer's disease associated with global population aging.
Statistics indicate that over 40% of individuals aged 55 and older in the United States are expected to develop dementia in their later years. Importantly, amyloid deposits may accumulate in the brain years before symptoms appear, suggesting that early detection could enable proactive measures to slow the disease's progression, including preventive treatments.
Dr. Maria Carrillo, chief science officer at the Alzheimer's Association, expressed optimism that this recent
will make accurate diagnoses more accessible.
Although several lab-developed tests exist to identify blood-based biomarkers linked to Alzheimer's, the Fujirebio test is the first to gain FDA clearance, marking a milestone in the field.
Carrillo noted that blood-based biomarkers are transforming our understanding and identification of Alzheimer's disease. However, there remain critical considerations for healthcare professionals regarding who should be tested and when.
Dr. Howard Fillit, co-founder of the Alzheimer's Drug Discovery Foundation, remarked on the significance of being able to diagnose Alzheimer's more readily with a simple blood test—comparable to cholesterol testing. He believes this innovation illustrates a new era in Alzheimer's research, where advancements in science and technology are leading to more accessible and effective diagnostic tools.
Scientists developing new diagnostic tool that can deliver health test results in two minutes
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Salmonella egg recall alert: 1.7M eggs yanked off shelves as outbreak sickens dozens in multistate health crisis
Salmonella outbreak linked to eggs sickens dozens across seven U.S. states- A salmonella outbreak linked to eggs has made at least 79 people sick across seven states, triggering a massive recall of 1.7 million eggs sold under multiple brands. The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) confirmed that the outbreak is tied to brown organic and brown cage-free eggs distributed by August Egg Company, based in Hilmar, California. The affected eggs were sold between February 3 and May 15, 2025, at major grocery stores like Walmart, Ralphs, Safeway, Save Mart, FoodMaxx, and Raley's across several states. With 21 hospitalizations and a large number of cases concentrated in California, federal officials are urging consumers to check their egg cartons immediately. Where were the eggs sold? The recalled eggs were distributed to stores in at least nine states , including: California Nevada Arizona Illinois Indiana Washington Wyoming New Mexico Nebraska Retailers affected include Walmart, Safeway, Raley's, Food 4 Less, Lucky, Save Mart , and others. Distribution occurred between February 3 and May 15, 2025 , depending on the region. How many people have gotten sick and where are the cases concentrated? According to the CDC, at least 79 people have become ill, and 21 of them were hospitalized due to salmonella infections linked to the recalled eggs. The majority of cases—63—were reported in California, followed by Nevada and Washington State with 4 cases each. Additional cases were found in Arizona, Kentucky, Nebraska, and New Jersey. Fortunately, no deaths have been reported so far. Live Events Scope of the outbreak 79 confirmed illnesses across seven states (AZ, CA, IL, IN, NE, NV, WA, WY, NM)—with symptom onset between Feb 24 and May 17, 2025, 21 hospitalizations , though no deaths reported . Cases span age 1 to 90 , median age 48; 59% female , 41% male ; majority (94%) are White. Around 90% of interviewed patients reported eating eggs before falling ill. Which egg brands are affected by the salmonella outbreak? The recall involves multiple brown organic and cage-free egg brands distributed by August Egg Company. These eggs have sell-by dates ranging from March 4 to June 19, 2025, and were sold in both local grocery stores and Walmart locations across California, Arizona, Nevada, Washington, New Mexico, Wyoming, Illinois, Indiana, and Nebraska. Customers are encouraged to check the plant number codes and brand names listed on the FDA and CDC websites to confirm if their eggs are part of the recall. Quick data snapshot Metric Value Confirmed cases 79 Hospitalizations 21 Deaths 0 Recall size 1.7 million dozen eggs Affected brands Over 20 (Clover, Raleys, Sunnyside…) States (illness) AZ, CA, IL, IN, NE, NV, WA, WY, NM Distribution period Feb 3 – May 15 (varied by region) Egg codes P-6562 or CA‑5330; Julian dates 032–126 What should consumers do if they have recalled eggs at home? The CDC strongly advises against eating any of the recalled eggs. Instead, they recommend throwing them away or returning them to the store where they were bought. People should also wash all surfaces and items that may have come into contact with the recalled eggs using hot, soapy water or clean them in a dishwasher to prevent further spread of bacteria. What you should do now Check your egg cartons —look for plant codes P‑6562 or CA‑5330 , and sell-by dates matching March 4–June 19 . Discard or return any matching eggs immediately. Clean and disinfect all surfaces and utensils that touched the eggs. Watch for symptoms and consult a healthcare provider if you experience them. What steps has August Egg Company taken to contain the outbreak? In a statement to the FDA, August Egg Company said it launched the voluntary recall 'out of an abundance of caution' to protect consumers who might still have the contaminated eggs at home. They explained that once the issue was identified, they began diverting all eggs from the affected plant to a pasteurizing facility, where eggs are heat-treated to kill any harmful bacteria. The company also confirmed it is conducting an internal review to strengthen safety protocols and avoid similar incidents in the future. What are the symptoms of salmonella and who is most at risk? Salmonella typically causes symptoms such as fever, diarrhea, and stomach cramps, which can last between 4 to 7 days. Most people recover without treatment, but in severe cases—especially among children under 5, seniors over 65, and those with weakened immune systems—hospitalization may be necessary. Every year, salmonella sickens an estimated 1.35 million people in the U.S., according to CDC data. How did the outbreak get traced back to the eggs? During an FDA inspection of a processing facility operated by August Egg Company, tests revealed a strain of salmonella that closely matched the one found in people who had fallen ill. This direct link helped investigators identify the eggs as the source of the outbreak and prompted the recall. FAQs: How do I check if my eggs are in the salmonella outbreak recall? Match the plant code and sell-by date on your brown organic or cage-free carton with the FDA recall list. What should I do if I ate recalled eggs linked to the salmonella outbreak? Monitor for fever, diarrhea or stomach cramps within 6–72 hours and call a doctor if symptoms appear.
India Today
3 hours ago
- India Today
Dementia, Alzheimer's or just brain fog? Here's how to tell the difference
For years, conditions like dementia and Alzheimer's disease were often brushed aside in India as issues of "old age" or even mistaken for personality with rising awareness and better healthcare access, families and doctors are starting to recognise these as medical concerns reported closer to home that deserve timely to the Alzheimer's and Related Disorders Society of India (ARDSI), more than 5.3 million Indians are currently living with dementia, and this number is expected to triple by 2050 due to the country's ageing DEMENTIA VS ALZHEIMER'S: WHAT'S THE DIFFERENCE?While people often use the terms interchangeably, dementia and Alzheimer's disease are not the same is an umbrella term, used to describe a group of symptoms that affect memory, thinking, and social abilities severely enough to interfere with daily life. It happens when cells in the brain slowly begin to die. In dementia, symptoms can include forgetfulness, confusion, having trouble speaking, having difficulty in comprehending conversations, pulling away, and change in is the most common type of dementia, accounting for 60% to 70% of all dementia cases in the of dementia as the disease and Alzheimer's as one of the main are other forms of dementia too, like vascular dementia, frontotemporal dementia, and Lewy body dementia. Each has different causes and Alzheimer's disease, the brain undergoes physical changes, including the build-up of abnormal proteins that slowly damage and kill brain leads to progressive memory loss, confusion, and changes in personality and dementia can strike in the 60s and above, symptoms are now striking as young as the 40s, known as young-onset DOES BRAIN FOG FIT IN?Unlike dementia and Alzheimer's, brain fog is not a medical diagnosis, but a term people use to describe a temporary state of mental cloudiness. Think of dementia as the disease and Alzheimer's as one of the main causes. () It can feel like difficulty concentrating, forgetfulness, or struggling to find words. Brain fog can be triggered by stress, lack of sleep, hormonal changes, or illness, including the after Covid-19 effects or long fog is usually reversible but dementia is not since it is a brain-shrinking disease. Brain fog can mimic some symptoms of dementia, like confusion, forgetting instructions of something you're can also happen because of an illness or a side effect of medication or a symptom of an underlying condition, according to Cleveland fog feels like difficulty concentrating, confusion, fatigue, forgetfulness, losing your train of thought, mental exhaustion, not having the right words, slow thought process and reaction time and trouble paying attention. Brain fog is usually reversible but dementia is not since it is a brain-shrinking disease. () In some cases, many lifestyle factors can trigger brain fog, signalling brain tumors, which may initially manifest with subtle cognitive DIAGNOSIS CAN MAKE A DIFFERENCEWhile there is no cure for dementia or Alzheimer's, early diagnosis can help slow progression and improve quality of sooner it is detected, the better it can be managed, whether through medication, lifestyle changes, or caregiver signs like frequently forgetting appointments, misplacing objects, repeating questions, or withdrawing from social activities should not be ignored, especially if they worsen over brain fog, though milder, can still be disruptive. Treating it often means improving sleep, managing stress, and correcting nutritional deficiencies (vitamin D or B12). If it persists, a medical evaluation can rule out more serious Watch
Indian Express
8 hours ago
- Indian Express
After Zepto in Mumbai, Blinkit in Pune faces action; FDA orders closure of dark store at Baner-Balewadi
The Maharashtra Food and Drug Administration (FDA) last week ordered the closure of a dark store associated with quick grocery delivery service Blinkit in Pune's Baner-Balewadi area for allegedly operating without a licence. Suresh Annapure, Joint Commissioner, FDA, Pune, told The Indian Express that the action was taken on June 5 when an inspection team found improper storage conditions at the facility run by Energy Darkstore Services, one of Blinkit's last-mile warehousing and partners. 'We have asked for proper documents to be submitted to issue a license. There are non-compliance issues, and without permission, they have been operating the store in the Baner-Balewadi area,' Annapure said. Sources said several issues were identified, including poor cleanliness and improper cold storage. Food Safety Officer Laxmikant Sawale said the action was taken after the raid revealed a lack of compliance with Schedule 4 of the Food Safety and Standards Act, 2006, which details the general hygienic and sanitary practices that food business operators must adhere to. 'We have directed them to submit a compliance report and then there will be a re-inspection,' Annapure said. The FDA's action is part of its ongoing crackdown on unsafe food storage practices across the state. Earlier this month, it suspended the food business licence of quick-commerce firm Zepto's parent company Kiranakart Technologies due to lapses found at at its dark store in Mumbai's Dharavi. The inspection was conducted by Food Safety Officer Ram Bodke, following instructions from Minister of State for FDA Yogesh Kadam and under the supervision of Mangesh Mane, Joint Commissioner of Food. The investigation revealed numerous violations of the Food Safety and Standards Act, 2006, as well as the related licensing regulations, according to the FDA. Visible fungal growth on food items, stagnant and clogged water near storage areas, which indicated poor sanitation, improper cold storage with temperatures not maintained as per norms, and wet, unclean floors and food products stored haphazardly, including directly on the ground, were some of the findings of the regulator.
